Jeffrey H. Murray

Array ( [id] => 4846440 [patent_doc_number] => 20080182848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Novel Process' [patent_app_type] => utility [patent_app_number] => 11/961673 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5001 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182848.pdf [firstpage_image] =>[orig_patent_app_number] => 11961673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894049 [patent_doc_number] => 20080103148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'CYCLIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 11/960989 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20197 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103148.pdf [firstpage_image] =>[orig_patent_app_number] => 11960989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685343 [patent_doc_number] => 20100120798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETY' [patent_app_type] => utility [patent_app_number] => 12/519993 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70365 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120798.pdf [firstpage_image] =>[orig_patent_app_number] => 12519993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814187 [patent_doc_number] => 20080194818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Dihydropteridione Intermediate Compounds' [patent_app_type] => utility [patent_app_number] => 11/958749 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14345 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194818.pdf [firstpage_image] =>[orig_patent_app_number] => 11958749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7504217 [patent_doc_number] => 08034961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives' [patent_app_type] => utility [patent_app_number] => 12/002407 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6844 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034961.pdf [firstpage_image] =>[orig_patent_app_number] => 12002407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628839 [patent_doc_number] => 20100004238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'FUSED HETEROCYCLIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/518596 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111958 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004238.pdf [firstpage_image] =>[orig_patent_app_number] => 12518596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546152 [patent_doc_number] => 20100016341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'ASPARTYL PROTEASE INHIBITORS CONTAINING A TRICYCLIC RING SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/517740 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25450 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016341.pdf [firstpage_image] =>[orig_patent_app_number] => 12517740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23941 [patent_doc_number] => 07795245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Heterobicyclic metalloprotease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/001043 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76512 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795245.pdf [firstpage_image] =>[orig_patent_app_number] => 12001043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753225 [patent_doc_number] => 20080161300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Heterobicyclic metalloprotease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/001041 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76600 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161300.pdf [firstpage_image] =>[orig_patent_app_number] => 12001041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553508 [patent_doc_number] => 07820678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 11/950674 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17251 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820678.pdf [firstpage_image] =>[orig_patent_app_number] => 11950674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267569 [patent_doc_number] => 20100298384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'NOVEL OXAZOLIDINONE COMPOUNDS AS ANTIINFECTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/517280 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43025 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298384.pdf [firstpage_image] =>[orig_patent_app_number] => 12517280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244961 [patent_doc_number] => 08202890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Pest control agent' [patent_app_type] => utility [patent_app_number] => 12/312866 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4035 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202890.pdf [firstpage_image] =>[orig_patent_app_number] => 12312866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432386 [patent_doc_number] => 20100152205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'CXCR2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/514732 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9723 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152205.pdf [firstpage_image] =>[orig_patent_app_number] => 12514732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307216 [patent_doc_number] => 20100069407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'CXCR2 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/514734 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6907 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069407.pdf [firstpage_image] =>[orig_patent_app_number] => 12514734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960627 [patent_doc_number] => 20080275052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/940382 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23121 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275052.pdf [firstpage_image] =>[orig_patent_app_number] => 11940382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904577 [patent_doc_number] => 20080113991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Pyridopyrazines and the use thereof as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/985031 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11497 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113991.pdf [firstpage_image] =>[orig_patent_app_number] => 11985031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164653 [patent_doc_number] => 08173661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Alpha-IIB-beta-3 inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/514286 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16724 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173661.pdf [firstpage_image] =>[orig_patent_app_number] => 12514286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571790 [patent_doc_number] => 08338436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Amorphous form of N-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide' [patent_app_type] => utility [patent_app_number] => 12/513884 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2698 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12513884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846451 [patent_doc_number] => 20080182859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Small organic molecule regulators of cell proliferation' [patent_app_type] => utility [patent_app_number] => 11/982718 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102492 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182859.pdf [firstpage_image] =>[orig_patent_app_number] => 11982718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307147 [patent_doc_number] => 20100069395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid compounds as protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/447324 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18331 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069395.pdf [firstpage_image] =>[orig_patent_app_number] => 12447324 [rel_patent_id] =>[rel_patent_doc_number] =>)